Onconomics Plus

What is Onconomics Plus?

Onconomics Plus is the most comprehensive Blood Gas Epigenic Profile (RGCC) in which it combines the evaluation of the Gene Expression Profile at the Epigenetic Level and Chemistry Sensitivity for Cytotoxic Drugs and Natural Substances.

Chemosensitivity, Epigenetic Analysis and Viability Tests (ONCONOMICS)

Epigenetic Analysis allows us to really analyze how malignant cells grow, multiply, develop new blood vessels, proliferate in other regions (metastases), which feed them and inhibit them. This result is validated with the viability assay, since the rate of gene expression does not always have a linear relation with the protein phenotype. Therefore, in micro-cultures, we confirm the viability of the cells when exposed to the active form of each drug by the Chemiosensitivity. The feasibility diagram below represents the percentage of viable cells compared to the primary population.

Natural Substances (ONCONOMICS EXTRACTS)

This test can identify more effective Natural Substances for the treatment of Tumor Cells and Cancer Stem Cells and increase the function of the Immune System.

Many of the substances tested support the immune system by reducing the number of cancer cells through the process of "Angiogenesis" or "Apoptosis".

The selection of tested Natural Substances follows with a base of Clinical Study and Scientific Evidence of each substance and its anti-cancer property. In addition, it is well documented that many natural agents are used in the development of drugs in the binding of the structure or in the design of drugs, including various chemotherapeutics.